Understanding IMD107 / OTULIN Haploinsufficiency
At a Glance
IMD107 is an inherited change in one OTULIN gene copy that can make skin and lung cells vulnerable to tissue damage from invasive Staph infections, even when routine immune blood tests look normal; symptoms can vary widely among family members.
If you or your child has been diagnosed with Immunodeficiency 107 (IMD107), you are dealing with an incredibly rare genetic condition [1]. It is completely normal to feel isolated or anxious, especially because the condition was only recently identified, and many doctors—including experienced specialists—may not have encountered it before.
IMD107 is also known as OTULIN haploinsufficiency (OHI). To understand the name, it helps to know that we usually have two working copies of every gene. In this condition, one copy of the OTULIN gene is missing or non-functional (this is called haploinsufficiency). While you still have one working copy, it does not produce enough of the OTULIN protein to protect certain parts of your body from specific types of tissue damage [1][2].
A Different Kind of Immune Gap
Most people think of “immunodeficiency” as having too few white blood cells or low antibody levels. However, IMD107 is unique because it is an incompletely penetrant condition. In genetics, incomplete penetrance refers to the proportion of variant carriers who actually develop the disease—meaning that even if you have the genetic change, you may not develop severe symptoms, or they may vary greatly between individuals [1][3].
The most striking feature of IMD107 is that routine immunological testing may be unremarkable [3][4]. This can be deeply frustrating for patients and families who know something is wrong. In most cases:
- White blood cell counts (CBC) are typically normal [3].
- The different types of immune cells (leukocyte subsets) often appear in the correct amounts [3][4].
- Standard tests for “how the immune system is working” often come back as “unremarkable” [4].
This happens because the defect in IMD107 isn’t found in the circulating blood cells that travel through your body. Instead, the problem is often localized in the structural cells of your organs, such as your skin cells (dermal fibroblasts) and lung tissue [3].
The Vulnerability to “Staph” and Tissue Death
The hallmark of IMD107 is an unusual susceptibility to a bacterium called Staphylococcus aureus (often called “Staph”) [2][5]. While many people carry Staph on their skin without issue, for someone with IMD107, this bacterium can cause invasive infections that lead to necrosis—the death of body tissue [1][3].
This occurs because the OTULIN protein normally acts as a defense for your cells against a specific toxin (the alpha-toxin) produced by Staph bacteria [3]. Without enough OTULIN, your skin and lung cells become unusually vulnerable to severe injury from this toxin [3]. These episodes are often severe and can follow:
Who is Affected?
IMD107 does not follow a strict timeline. It is a lifelong genetic susceptibility that can stay hidden for years until it is triggered by an infection or injury. Research shows that it can present at almost any point in life:
- Childhood: Some patients have their first severe episode in their early teens (for example, at age 13) [4].
- Adulthood: Other patients may not experience a life-threatening event until they are adults [6].
Because it is autosomal dominant, the condition can be passed from a parent to a child. However, because it is “incompletely penetrant,” a parent might carry the gene change and never get sick, while their child might have severe symptoms [1][3]. This makes genetic counseling a vital part of managing the condition for the whole family.
Why Diagnosis is Often Delayed
Because your routine blood work looks healthy, many doctors may assume your immune system is fine and treat your infections as “bad luck.” It often takes a pattern of repeated, severe tissue damage or necrotic infections to prompt the specialized genetic testing needed to investigate the OTULIN gene [1].
If you have been diagnosed with IMD107, it means your care team has identified a pathogenic genetic variant that correlates with your clinical history. This diagnosis is the first step toward moving away from general treatments and toward an individualized plan that accounts for your body’s specific needs in fighting off Staph and protecting your tissues.
What is Known and What is Uncertain
Because IMD107 is extremely rare, the natural history and exact penetrance estimates are still limited. Much of the evidence regarding mechanisms and treatment comes from small cohorts, laboratory studies, or case reports, meaning some medical recommendations will need to be carefully individualized by your care team rather than following a rigid protocol.
Common questions in this guide
What is IMD107 or OTULIN haploinsufficiency?
Can someone with IMD107 have normal immune blood tests?
What can trigger tissue necrosis in IMD107?
How is IMD107 diagnosed?
Can IMD107 be passed from a parent to a child?
Get notified when new evidence is published on immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (6)
- 1
Novel genotypes, phenotypes, and triggers in humans with OTULIN haploinsufficiency.
van der Linden TJ, Arts RJW, Biggs CM, et al.
Journal of human immunity 2025; (1(4)) doi:10.70962/jhi.20250018.
PMID: 41293556 - 2
OTULIN-related conditions: Report of a new case and review of the literature using GenIA.
Caballero-Oteyza A, Crisponi L, Peng XP, et al.
Research square 2024; doi:10.21203/rs.3.rs-3950863/v2.
PMID: 38712244 - 3
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin.
Spaan AN, Neehus AL, Laplantine E, et al.
Science (New York, N.Y.) 2022; (376(6599)):eabm6380 doi:10.1126/science.abm6380.
PMID: 35587511 - 4
Failure to Close: An Unexpected Surgical Complication Reveals OTULIN Haploinsufficiency.
Nguyen J, Kim CF, Ramirez AA, Vogel TP
ACR open rheumatology 2025; (7(3)):e11800 doi:10.1002/acr2.11800.
PMID: 40084498 - 5
OTULIN haploinsufficiency predisposes to environmentally directed inflammation.
Staels F, Bücken L, De Vuyst L, et al.
Frontiers in immunology 2024; (15()):983686 doi:10.3389/fimmu.2024.983686.
PMID: 38827742 - 6
OTULIN Haploinsufficiency-Related Fasciitis and Skin Necrosis Treated by TNF Inhibition.
Arts RJW, van der Linden TJ, van der Made CI, et al.
Journal of clinical immunology 2023; (44(1)):10 doi:10.1007/s10875-023-01630-4.
PMID: 38129331
This page is for informational purposes only and does not constitute medical advice. A clinical immunologist or genetics professional should interpret your OTULIN result and guide monitoring for you or your child.